Department of Imaging & Interventional Radiology, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, Hong Kong SAR, China.
Department of Imaging & Interventional Radiology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
Breast J. 2022 Oct 31;2022:3882936. doi: 10.1155/2022/3882936. eCollection 2022.
We compared the clinico-radio-pathological characteristics of breast cancer detected through mammogram (MMG) and ultrasound (USG) and discuss the implication of the choice of imaging as the future direction of our recently launched local screening program.
Retrospective study of 14613 Hong Kong Chinese female patients with histologically confirmed breast cancer registered in the Hong Kong Breast Cancer Registry between January 2006 and February 2020. Patients were classified into four groups based on the mode of breast cancer detection (detectable by both mammogram and ultrasound (MMG+/USG+), mammogram only (MMG+/USG-), ultrasound only (MMG-/USG+), or not detectable by either (MMG-/USG-). Characteristics of breast cancer detected were compared, including patient demographics, breast density on MMG, mode of presentation, tumour size, histological type, and staging. Types of mammographic abnormalities were also evaluated for MMG+ subgroups.
85% of the cancers were detectable by MMG, while USG detected an additional 9%. MMG+/USG+ cancers were larger, more advanced in stage, often of symptomatic presentation, and commonly manifested as mammographic mass. MMG+/USG- cancers were more likely of asymptomatic presentation, manifested as microcalcifications, and of earlier stage and to be ductal carcinoma in situ. MMG-/USG+ cancers were more likely seen in young patients and those with denser breasts and more likely of symptomatic presentation. MMG-/USG- cancers were often smaller and found in denser breasts.
Mammogram has a good detection rate of cancers in our local population. It has superiority in detecting early cancers by detecting microcalcifications. Our current study agrees that ultrasound is one of the key adjunct tools of breast cancer detection.
我们比较了通过乳房 X 光(MMG)和超声(USG)检测到的乳腺癌的临床-放射-病理特征,并讨论了选择影像学作为我们最近推出的本地筛查计划未来方向的意义。
回顾性研究了 2006 年 1 月至 2020 年 2 月期间在香港乳腺癌登记处登记的 14613 名经组织学证实的香港华裔女性患者。根据乳腺癌检测方式(MMG 和 USG 均能检测到(MMG+/USG+)、仅 MMG 能检测到(MMG+/USG-)、仅 USG 能检测到(MMG-/USG+)或两者均不能检测到(MMG-/USG-),将患者分为四组。比较了不同组别乳腺癌的特征,包括患者人口统计学特征、MMG 上的乳腺密度、表现方式、肿瘤大小、组织学类型和分期。还评估了 MMG+亚组的乳腺 X 光异常类型。
85%的癌症可通过 MMG 检测到,而 USG 额外检测到 9%的癌症。MMG+/USG+癌症更大,分期更晚,常为症状性表现,常表现为乳腺肿块。MMG+/USG-癌症更常为无症状表现,表现为微钙化,分期更早,常为导管原位癌。MMG-/USG+癌症多见于年轻患者和乳腺密度较高的患者,更常表现为症状性。MMG-/USG-癌症常较小,且发生在乳腺密度较高的患者中。
MMG 对本地区人群的癌症有较好的检出率。它通过检测微钙化在早期癌症的检测方面具有优势。我们目前的研究同意,超声是乳腺癌检测的关键辅助工具之一。